Hunan Jingfeng Pharmaceutical Co.,Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 395.86 million compared to CNY 292.03 million a year ago. Revenue was CNY 402.01 million compared to CNY 313.54 million a year ago.

Net loss was CNY 11.46 million compared to net income of CNY 83.79 million a year ago. Basic loss per share from continuing operations was CNY 0.013 compared to basic earnings per share from continuing operations of CNY 0.0952 a year ago. Diluted loss per share from continuing operations was CNY 0.013 compared to diluted earnings per share from continuing operations of CNY 0.0952 a year ago.